Effects of Exercise Intensity in Obese Children and Adolescents
A Multi-centre Randomized Controlled Trial Examining the Effects of High Intensity Interval Training on Cardio-metabolic Outcomes in Obese Children and Adolescents
The prevalence of paediatric obesity has increased over the last two decades and with it, an increased diagnosis of lifestyle-related diseases in children and adolescents. High intensity interval training has recently been explored as an alternate to traditional aerobic exercise in adults with chronic disease and has potential to induce rapid reversal of subclinical disease markers in obese children and adolescents.
High intensity interval training has recently been explored as an alternate to traditional aerobic exercise in adults with chronic disease and has potential to induce rapid reversal of subclinical disease markers in obese children and adolescents.
Goal: The primary aim of this randomised controlled trial is to evaluate the effectiveness of a high intensity interval training intervention on myocardial function, vascular function and visceral adipose tissue in obese children and adolescents at baseline, three and twelve months.
Method: Multi-centre randomised controlled trial of 100 obese children and adolescents in the cities of Trondheim (Norway) and Brisbane (Australia). Participants will be randomised to (1) high intensity interval training, (2) moderate intensity continuous training or (3) nutrition advise. Participants will partake in supervised exercise training and/or nutrition consultations for 3 months. Measurements for all study endpoints will occur at baseline, 3 months (post intervention) and 12 months (follow up).
Scientific Significance : This randomised controlled trial will general substantial information regarding the effects of exercise intensity on paediatric obesity, specifically the cardio-metabolic health of this at-risk population. It is expected that communication of results will allow for more robust and realistic guidelines regarding exercise prescription in this population to be formed while outlining the benefits of high intensity interval training on subclinical markers of disease.
Tutkimuksen yleiskatsaus
Tila
Ehdot
Yksityiskohtainen kuvaus
Worldwide, childhood overweight and obesity rates are approximately 10%, this high incidence attributed to a physically inactive lifestyle and inappropriate nutrition. Early cohort studies illustrated that fifty per cent of obese children became obese adults and consequently had an higher risk for metabolic syndrome than obese adults who were not obese as children. Both female and male overweight children and adolescents had a 30% increase in all cause mortality. The increases in risk of death were independent of adult body mass index.
Systematic reviews suggest that lifestyle and exercise interventions in obese children and adolescents can lead to improvements in anthropometric and cardio-metabolic outcomes, but these are not inclusive of several important outcomes such as myocardial and vascular function or visceral adipose tissue.
Opintotyyppi
Ilmoittautuminen (Todellinen)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Obese (BMI ≥ 95th percentile - age and sex specific criteria)
Exclusion Criteria:
- Elevated blood pressure (≥ 95th percentile for systolic or diastolic values)
- Congenital heart disease
- Coronary artery disease
- Family history of hypertropic obstructive cardiomyopathy
- Any abnormality during rest or stress echocardiography which indicates it would be unsafe to participate
- Self reported kidney failure
- Any major organ transplant
- Considerable pulmonary disease including severe or poorly controlled asthma
- Smoking
- Diabetes
- Epilepsy or a history of seizures
- Orthopaedic or neurological limitations to exercise
- Diagnosed attention deficit hypersensitivity disorder
- Steroid medications
- Participation in another research study
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Ennaltaehkäisy
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Yksittäinen
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: High intensity interval training
10-minute warm up at 60-70% of maximal heart rate (HRmax).
Then walking, running or cycling at 85-95% of maximal heart rate at intervals of 4 x 4 minutes, with 3 minute active breaks (50-70% of HRmax) between intervals.
A 5-minute cool down period.
|
Twelve weeks of 2-3 supervised training sessions each week.
Muut nimet:
healthy food choices, portion sizes and regular mealtimes
|
|
Kokeellinen: Moderate intensity continuous training
walking, running or cycling continuously at 60-70% HRmax for 44 minutes.
|
healthy food choices, portion sizes and regular mealtimes
Twelve weeks of 2-3 supervised training sessions each week.
Muut nimet:
|
|
Active Comparator: nutritional advice
10 individual nutrition consultations with an accredited dietitian over the 12 month period.
Content of consultations will include healthy food choices, portion sizes and regular mealtimes.
|
healthy food choices, portion sizes and regular mealtimes
|
|
Ei väliintuloa: non-obese children
100 healthy non-obese children aged 7-16 (controls)
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Peak systolic tissue velocity
Aikaikkuna: 12 weeks
|
systolic tissue Doppler velocity assessed during resting and stress echocardiography
|
12 weeks
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Subcutaneous and total abdominal adipose tissue
Aikaikkuna: 12 weeks, 12 months
|
Assessed using MRI
|
12 weeks, 12 months
|
|
Cardiorespiratory fitness (VO2peak)
Aikaikkuna: 12 weeks, 12 months
|
Assessed using a maximal treadmill test
|
12 weeks, 12 months
|
|
Body composition
Aikaikkuna: 12 weeks, 12 months
|
Assessed using DXA (UQ), BodPod (NTNU)
|
12 weeks, 12 months
|
|
Blood biochemistry
Aikaikkuna: 12 weeks, 12 months
|
Analysed for lipids, glucose, insulin, inflammatory makers, satiety hormones, oxidative stress
|
12 weeks, 12 months
|
|
Physical activity
Aikaikkuna: 12 weeks, 12 months
|
Assessed through 7 day accelerometry
|
12 weeks, 12 months
|
|
Dietary analysis
Aikaikkuna: 12 weeks, 12 months
|
Assessed through a three-day food record
|
12 weeks, 12 months
|
|
Myocardial structure and cardiac adipose tissue (UQ)
Aikaikkuna: 12 weeks
|
Assessed through cardiac MRI; participants > 12 years only
|
12 weeks
|
|
Arterial stiffness
Aikaikkuna: 12 weeks, 12 months
|
Assessed through pulse wave velocity and pulse wave analysis
|
12 weeks, 12 months
|
|
Autonomic function
Aikaikkuna: 12 weeks, 12 months
|
Assessed through heart rate variability and heart rate recovery
|
12 weeks, 12 months
|
|
Quality of life
Aikaikkuna: 12 weeks, 12 months
|
Assessed through the Paediatric Quality of Life Inventory
|
12 weeks, 12 months
|
|
Visceral adipose tissue
Aikaikkuna: 12 weeks, 12 months
|
assessed by magnetic resonance imaging (MRI)
|
12 weeks, 12 months
|
|
Vascular function
Aikaikkuna: 12 weeks, 12 months
|
Assessed through flow mediated dilation procedure
|
12 weeks, 12 months
|
|
Peak systolic tissue velocity
Aikaikkuna: 12 months
|
systolic tissue Doppler velocity assessed during resting and stress echocardiography
|
12 months
|
Yhteistyökumppanit ja tutkijat
Yhteistyökumppanit
Julkaisuja ja hyödyllisiä linkkejä
Yleiset julkaisut
- Dias KA, Coombes JS, Green DJ, Gomersall SR, Keating SE, Tjonna AE, Hollekim-Strand SM, Hosseini MS, Ro TB, Haram M, Huuse EM, Davies PS, Cain PA, Leong GM, Ingul CB. Effects of exercise intensity and nutrition advice on myocardial function in obese children and adolescents: a multicentre randomised controlled trial study protocol. BMJ Open. 2016 Apr 4;6(4):e010929. doi: 10.1136/bmjopen-2015-010929.
- Dias KA, Ingul CB, Tjonna AE, Keating SE, Gomersall SR, Follestad T, Hosseini MS, Hollekim-Strand SM, Ro TB, Haram M, Huuse EM, Davies PSW, Cain PA, Leong GM, Coombes JS. Effect of High-Intensity Interval Training on Fitness, Fat Mass and Cardiometabolic Biomarkers in Children with Obesity: A Randomised Controlled Trial. Sports Med. 2018 Mar;48(3):733-746. doi: 10.1007/s40279-017-0777-0.
- Ingul CB, Dias KA, Tjonna AE, Follestad T, Hosseini MS, Timilsina AS, Hollekim-Strand SM, Ro TB, Davies PSW, Cain PA, Leong GM, Coombes JS. Effect of High Intensity Interval Training on Cardiac Function in Children with Obesity: A Randomised Controlled Trial. Prog Cardiovasc Dis. 2018 Jul-Aug;61(2):214-221. doi: 10.1016/j.pcad.2018.01.012. Epub 2018 Feb 13.
- Dias KA, Ramos JS, Wallen MP, Davies PSW, Cain PA, Leong GM, Ingul CB, Coombes JS, Keating SE. Accuracy of Longitudinal Assessment of Visceral Adipose Tissue by Dual-Energy X-Ray Absorptiometry in Children with Obesity. J Obes. 2019 Nov 3;2019:2193723. doi: 10.1155/2019/2193723. eCollection 2019.
- Dias KA, Spence AL, Sarma S, Oxborough D, Timilsina AS, Davies PSW, Cain PA, Leong GM, Ingul CB, Coombes JS. Left ventricular morphology and function in adolescents: Relations to fitness and fatness. Int J Cardiol. 2017 Aug 1;240:313-319. doi: 10.1016/j.ijcard.2017.03.047. Epub 2017 Mar 11.
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Todellinen)
Opintojen valmistuminen (Todellinen)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Arvio)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 2009/1313
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .